UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Sep 14, 2026
Sale
Calculated transaction value
$783.32K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Sep 11, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$497.11
Sep 11, 2026
Close before public filing
$497.11
Sep 11, 2026
Return since public filing
+1.12%
Through Sep 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,560 shares @ $502.13
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000140
Filing cohort
Transactions in this filing
Showing 14 of 14
Trades
14
Issuers
1
Estimated value
$5.88M
Buys / sales
0 / 12
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Sep 11, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $666.13K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $1.06M |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $509.45K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $101.92K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $238.41K |
| United Therapeutics Corp UTHR Current | Sale | Sep 11, 2026 | $783.32K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $427.63K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $357.83K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $41.41K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $262.34K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $162.34K |
| United Therapeutics Corp UTHR | Sale | Sep 11, 2026 | $142.3K |
| United Therapeutics Corp UTHR | Exercise | Sep 11, 2026 | $0 |